Respiratory Syncytial Virus
June 8th, 20244 years later, COVID remains a year-round threat. Here’s why this virus isn’t seasonal quite yet – MASHAHER
- June 8th, 2024
FDA approves GSK RSV vaccine for adults 50 to 59 – MASHAHER
- March 1st, 2024
CDC shortens 5-day COVID isolation, updates guidance on masks and testing in new 2024 recommendations – MASHAHER
